Skip to main content

Table 8 Characteristics of patients with LM before the treatment of alectinib, n = 9

From: Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study

Evidence of LM diagnosis

Symptoms + MRI + CSF, n = 1

Symptoms + MRI, n = 7

MRI, n = 1

Accompanied with BM

n = 5

Previous history of ALK-TKI

ALK-TKI naive, n = 4

Crizotinib-resistant, n = 2

Other second generation ALK-TKIs, n = 3

Uncontrolled CNS metastases

n = 9

CNS-related symptoms

n = 8

ECOG

 

 0–1

 ≥ 2

n = 1

n = 8

Number of patients needed mannitol or corticosteroids

n = 7